Fighting Fire with Fire: Is it Time to Use Probiotics to Manage Pathogenic Bacterial Diseases?

@article{Heineman2012FightingFW,
  title={Fighting Fire with Fire: Is it Time to Use Probiotics to Manage Pathogenic Bacterial Diseases?},
  author={John L. Heineman and Sara Bubenik and Stephen A McClave and Robert G. Martindale},
  journal={Current Gastroenterology Reports},
  year={2012},
  volume={14},
  pages={343-348}
}
Probiotics, when considered in clinical practice, have traditionally been used for prophylaxis; however, there is growing data suggesting treatment benefits in numerous disease states. In this review, we focus on probiotics as treatment for and prevention of several acute and chronic infectious processes including Helicobacter pylori, Clostridium difficile, necrotizing enterocolitis, ventilator-associated pneumonia, vancomycin-resistant enterococci, and nonalcoholic fatty liver disease. It is… 
Bugs or Drugs: Are Probiotics Safe for Use in the Critically Ill?
TLDR
Use for probiotics in prevention and treatment is focused on, current concerns regarding their use are addressed, and a protocol for safe use of probiotics is proposed in the critically ill patient is proposed.
The function of probiotics on the treatment of ventilator‐associated pneumonia (VAP): facts and gaps
TLDR
Probiotic safety, the therapeutic properties of probiotics, the probiotic strains used and the action of the probiotics mechanism are reviewed, and the therapeutic effects of probiotic treatment procedures for VAP are compared to those of antibiotics.
Appraisal Of Probiotics And Prebiotics In Gastrointestinal Infections
TLDR
The combination of probiotics and prebiotics in a synbiotic has not also been studied well, but might improve the survival of the bacteria crossing the upper part of GIT, thereby enhancing their effect in the large bowel.
Microbial regulation of allergic responses to food
TLDR
It is hypothesized that alterations in the microbiome interfere with immune system maturation, resulting in impairment of IgA production, reduced abundance of regulatory T cells, and Th2-skewing of baseline immune responses which drive aberrant responses to innocuous (food) antigens.
Colonization with Escherichia coli EC 25 protects neonatal rats from necrotizing enterocolitis
TLDR
E. coli EC 25, which was originally isolated from healthy rats, efficiently colonized the intestine and protected from NEC following introduction to newborn rats with formula at 106 or 108 cfu.
Vaccine against Helicobacter pylori: Inevitable approach.
TLDR
A route is drawn to define the best adopted strategy against this rogue bacterium, and the best reasonable and logical approach is to recommend prophylactic H. pylori vaccine among children as an obligatory national program to limit primary colonization.
Vaccine against Helicobacter pylori: Inevitable approach.
TLDR
A route is drawn to define the best adopted strategy against this rogue bacterium, and the best reasonable and logical approach is to recommend prophylactic H. pylori vaccine among children as an obligatory national program to limit primary colonization.
...
...

References

SHOWING 1-10 OF 57 REFERENCES
Antibiotics or probiotics as preventive measures against ventilator-associated pneumonia: a literature review
TLDR
Prophylactic use of antibiotics in critically ill patients is effective in reducing the incidence of VAP and the efficacy of probiotics improves when these agents are provided to the mouth and the intestines simultaneously.
Probiotics and prevention of neonatal necrotizing enterocolitis
TLDR
The evidence does support a future role for probiotics in the prevention of NEC, but it is of utmost importance to first ensure that a safe and high-quality product meeting rigorous standards will be provided to these at-risk infants.
Probiotics in human medicine.
TLDR
The revised definition of the term 'probiotic' was revised and the evidence for the effect of live preparations on the human host was considered and some evidence from work with animals is presented which is helpful in understanding the potential benefits of this sort of treatment.
Probiotics for treatment of Clostridium difficile-associated colitis in adults.
TLDR
There is insufficient evidence to recommend probiotic therapy as an adjunct to antibiotic therapy for C. difficile colitis, and there is no evidence to support the use of probiotics alone in the treatment of C. diffuse colitis.
Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease
  • L. Mcfarland
  • Medicine, Biology
    The American Journal of Gastroenterology
  • 2006
TLDR
Three types of probiotics (Saccharomyces boulardii, Lactobacillus rhamnosus GG, and probiotic mixtures) significantly reduced the development of antibiotic-associated diarrhea.
Probiotics for prevention of necrotizing enterocolitis in preterm infants.
TLDR
Enteral supplementation of probiotics prevents severe NEC and all cause mortality in preterm infants and a review of available evidence supports a change in practice.
Using the good to beat out the bad: probiotics for eliminating vancomycin-resistant enterococci colonization.
  • A. Kim
  • Medicine, Biology
    Journal of clinical gastroenterology
  • 2011
TLDR
A novel way to eliminate the carrier state of VRE infection in hospitalized children by using a probiotic supplement, and the idea is that beneficial intestinal organisms, called probiotics, can out-compete the virulent VRE, thereby decreasing colonization, and eventually decrease infection in the host or spread to others in close contact with the carrier.
Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial.
TLDR
These pilot data suggest that L. rhamnosus GG is safe and efficacious in preventing VAP in a select, high-risk ICU population.
Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial
TLDR
Consumption of a probiotic drink containing L casei, L bulgaricus, and S thermophilus can reduce the incidence of antibiotic associated diarrhoea and C difficile associated diarrhaoa and has the potential to decrease morbidity, healthcare costs, and mortality if used routinely in patients aged over 50.
Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication
TLDR
Saccharomyces boulardii is an effective and safe treatment for prevention of antibiotic-associated diarrhoea when given concomitantly to patients receiving H. pylori eradication.
...
...